AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 295: L171-L177, 2008. First published April 25, 2008; doi:10.1152/ajplung.00457.2007
1040-0605/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/1/L171    most recent
00457.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Moynihan, B.
Right arrow Articles by Martin, J. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moynihan, B.
Right arrow Articles by Martin, J. G.

MAP kinases mediate interleukin-13 effects on calcium signaling in human airway smooth muscle cells

Barry Moynihan,1 Barbara Tolloczko,1 Marie-Claire Michoud,1 Meiyo Tamaoka,1 Pasquale Ferraro,2 and James G. Martin1

1Meakins-Christie Laboratories, Department of Medicine, McGill University; and 2Notre Dame Hospital, Universite de Montreal, Montreal, Canada

Submitted 1 November 2007 ; accepted in final form 21 April 2008

Interleukin-13 (IL-13) has been strongly implicated in the pathogenesis of allergic asthma through animal models that have shown that IL-13 is both necessary and sufficient to cause airway hyperresponsiveness (AHR). Airway smooth muscle (ASM) is a primary effector of AHR, and IL-13 increases the responsiveness of ASM, by increasing Ca2+ release intracellularly, to bronchoconstrictors such as histamine. The mechanisms and signaling pathways mediating this effect are incompletely understood. We have investigated the pathways through which IL-13 regulates the Ca2+ response to histamine in primary human ASM cell cultures. Functional IL-13 receptors were demonstrated by IL-13-mediated phosphorylation of signal transducer and activator of transcription 6 (STAT6) and mitogen-activated protein kinases (MAPKs). IL-13 increased Ca2+ responses to histamine. The augmentation of Ca2+ signaling was not affected by inhibition of STAT6 or p38 MAPK signaling but was prevented by concurrent inhibition of c-jun N-terminal kinase (JNK) and extracellular signal-related kinase (ERK) MAPKs. This inhibition did not affect the IL-13-induced increase in histamine receptors. We conclude that IL-13 induces potentiation of Ca2+ responses to contractile agonists by affecting mechanisms downstream of receptors. JNK and ERK MAPKs modulate these mechanisms.

lung; allergy; inflammation; cytokines; mitogen-activated protein kinase



Address for reprint requests and other correspondence: J. G. Martin, Meakins-Christie Laboratories, Dept. of Medicine, McGill Univ., 3626 St. Urbain, Montreal, Quebec, H2X 2P2 Canada (e-mail: james.martin{at}mcgill.ca)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.